Cardiff Oncology Inc. (CRDF)
NASDAQ: CRDF
· Real-Time Price · USD
2.05
-0.03 (-1.44%)
At close: Sep 12, 2025, 3:52 PM
Cardiff Oncology Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for CRDF stock have an median target of 10, with a low estimate of 3.5 and a high estimate of 10. The median target predicts an increase of 387.80% from the current stock price of 2.05.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 3.5 | 7.83 | 10 | 10 |
| Change | 70.73% | 281.95% | 387.80% | 387.80% |
Latest Analyst Insight Report
HC Wainwright & Co. maintains a Buy rating on Card... Unlock content with Pro Subscription
Updated Aug 06, 2025
| Rating | Dec 24 | Feb 25 | May 25 | Jun 25 | Jul 25 | Aug 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 0 | 0 | 0 |
| Buy | 1 | 0 | 0 | 0 | 1 | 1 |
| Hold | 0 | 0 | 0 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Financial Forecast this Year
Revenue This Year
423.75K
from 683K
Increased by -38%
Revenue Next Year
328.75K
from 423.75K
Increased by -22.4%
EPS This Year
-0.83
from -0.95
Increased by 12.6%
EPS Next Year
-0.87
from -0.83
Increased by -4.8%